Axsome Therapeutics, Inc. (AXSM)

185.76 +8.49 (+4.79%) USD  |  NASDAQ  |  Jan 20, 13:20
More

Axsome Therapeutics Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for AXSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
MannKind Corp. Upgrade